1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Indication Bioscience LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Atorvo+™ in Healthy Adult Participants Atorvo+™ (Arm1), Atorvo+™ +CBD (Arm 2), Atorvo+™ +CBD (Arm 3) - Coronary Heart Disease, Dyslipidemias | Phase 1 | Completed | Indication Bioscience LLC | 24 | 2025-01-28 | 2025-12-19 |
Coronary Disease (1) · Dyslipidemias (1)
26S proteasome non-ATPase regulatory subunit 13 (1)
Australia (1)
James E Smeeding (1)